Catheter Precision, Inc. Shareholders' Equity
Catheter Precision, Inc. (VTAK) had Shareholders' Equity of $17.56 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $17.56M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.57M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.05M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.78M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $17.56M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $9.57M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $7.05M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.78M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.79M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $7.92M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $11.76M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $12.83M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $14.32M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $18.52M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $21.19M 10-Q · filed 2025-05-14 | |
| 2023-09-30 | $21.87M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $23.79M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $35.86M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $9.26M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $12.51M 10-Q · filed 2023-12-21 | |
| 2022-06-30 | $9.79M 10-Q · filed 2023-12-21 | |
| 2022-03-31 | $18.11M 10-Q · filed 2023-12-21 | |
| 2021-12-31 | $13.67M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $21.55M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $21.26M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $15.14M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $21.15M 10-K · filed 2023-03-28 | |
| 2020-09-30 | $30.54M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $26.98M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $26.47M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $33.15M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $41.74M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $51.90M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $59.80M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $66.73M 10-K · filed 2021-03-17 | $66.70M 10-K · filed 2019-03-15 |
| 2018-09-30 | $6.48M 10-Q · filed 2019-11-29 | |
| 2018-06-30 | $9.78M 10-Q · filed 2019-11-29 | |
| 2018-03-31 | -$8.91M 10-Q · filed 2019-11-29 | |
| 2017-12-31 | -$7.62M 10-K · filed 2020-03-11 | |
| 2016-12-31 | -$380.00K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |